Oral isotretinoin for acne: a complete overview

References

• Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–1534.
   PubMed Web of Science ®Google Scholar
• Layton AM, Henderson CA, and Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;19(4):303–308.
   PubMed Web of Science ®Google Scholar
• Villani A, Annunziata MC, Abategiovanni L, et al. Teledermatology for acne patients: how to reduce face-to-face visits during COVID-19 pandemic. J Cosmet Dermatol. 2020 Aug;19(8):1828.
   PubMed Web of Science ®Google Scholar
• Ellington E. Isotretinoin: risk or benefit to mental health in youth? J Psychosoc Nurs Ment Health Serv. 2022 Feb;60(2):7–9.
   PubMed Web of Science ®Google Scholar
• **Drake L, Reyes-Hadsall S, Barbieri JS, et al. New developments in topical acne therapy. Am J Clin Dermatol. 2022 Mar;23(2):125–136.
   PubMed Web of Science ®Google Scholar
• Al Muqarrab F, Almohssen A. Low-dose oral isotretinoin for the treatment of adult patients with mild-to-moderate acne vulgaris: systematic review and meta-analysis. Dermatol Ther. 2022 Jan;9:e15311.
   Google Scholar
• Macek C. Synthetic vitamin A analogue (isotretinoin) awaiting approval for cystic acne therapy. JAMA. 1982;247(13):1800–1801.
   PubMedGoogle Scholar
• Isotretinoin. Annex I, II, III. European Nedicines Agency (ΕΜΕΑ). [ cited 2019 May 19]. cited: https://www.ema.europa.eu/en/documents/referral/roaccutane-article-30-referral-annex-i-ii-iii_en.pdf.
   Google Scholar
• Colburn W, Gibson D, Wiens R, et al. Food increases the bioavailability of isotretinoin. J Clin Pharmacol. 1983;23(11–12):534–539.
   PubMed Web of Science ®Google Scholar
• Webster GF, Leyden JJ, Gross JA. Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study. J Am Acad Dermatol. 2013;69(5):762–767.
   PubMed Web of Science ®Google Scholar
• Wiegand UW, Chou RC. Pharmacokinetics of oral isotretinoin. J Am Acad Dermatol. 1998;39(2):8–12.
   Web of Science ®Google Scholar
• Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. 2006;19(5):272–279.
   PubMed Web of Science ®Google Scholar
• Nelson AM, Gilliland KL, Cong Z, et al. 13-cis retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 2006;126(10):2178–2189.
   PubMed Web of Science ®Google Scholar
• Melnik BC. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol. 2017;97(2):173–181.
   PubMed Web of Science ®Google Scholar
• Shi G, Liao P-Y, Cai X-L, et al. FoxO1 enhances differentiation and apoptosis in human primary keratinocytes. Exp Dermatol. 2018;27(11):1254–1260.
   PubMed Web of Science ®Google Scholar
• Norris DA, Osborn R, Robinson W, et al. Isotretinoin produces significant inhibition of monocyte and neutrophil chemotaxis in vivo in patients with cystic acne. J Invest Dermatol. 1987;89(1):38–43.
   PubMed Web of Science ®Google Scholar
• Papakonstantinou E, Aletras AJ, Glass E, et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol. 2005;125(4):673–684.
   PubMed Web of Science ®Google Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e33.
   PubMed Web of Science ®Google Scholar
• Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–1268.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Krakowski AC, Piggott C, et al. American Acne and Rosacea Society. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013 May;131(Suppl 3):S163–86.
   PubMed Web of Science ®Google Scholar
• Dessinioti C, Zouboulis CC, Bettoli V, et al. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol. 2020 Apr 11;34(10):2229–2240.
   PubMed Web of Science ®Google Scholar
• Thiboutot DM, Dreno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the global alliance to improve outcomes in acne. J Am Acad Dermatol. 2018;78(2 Suppl 1):S1–23.
   PubMed Web of Science ®Google Scholar
• Fallah H, Rademaker M. Isotretinoin in the management of acne vulgaris: practical prescribing. Int J Dermatol. 2021 Apr;60(4):451–460.
   PubMed Web of Science ®Google Scholar
• Lehucher-Ceyrac D, De La Salmoniere P, Chastang C, et al. Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients. Dermatology. 1999;198(3):278–283.
   PubMed Web of Science ®Google Scholar
• Borghi A, Mantovani L, Minghetti S, et al. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011;25(9):1094–1098.
   PubMed Web of Science ®Google Scholar
• Quereux G, Volteau C, N’Guyen JM, et al. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology. 2006;212(2):168–176.
   PubMed Web of Science ®Google Scholar
• Costa CS, Bagatin E, Martimbianco ALC, et al. Oral isotretinoin for acne. Cochrane Database Syst Rev. 2018;11. Art. No.: CD009435. DOI:10.1002/14651858.CD009435.pub2
   PubMedGoogle Scholar
• Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A, et al. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatol Ther. 2021 Jan;34(1):e14438.
   PubMed Web of Science ®Google Scholar
• Lee JW, Yoo KH, Park KY, et al. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol. 2011 Jun;164(6):1369–1375.
   PubMed Web of Science ®Google Scholar
• Akman A, Durusoy C, Senturk M, et al. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res. 2007 Dec;299(10):467–473.
   PubMed Web of Science ®Google Scholar
• Ahmad HM. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin. Dermatol Ther. 2015 May-Jun;28(3):151–157.
   PubMed Web of Science ®Google Scholar
• Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial. Indian J Dermatol Venereol Leprol. 2011 Nov-Dec;77(6):688–694.
   PubMed Web of Science ®Google Scholar
• Boyraz N, Mustak PK. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris. Int J Dermatol. 2013 Oct;52(10):1265–1267.
   PubMed Web of Science ®Google Scholar
• Rademaker M, Wishart JM, Birchall NM. Isotretinoin 5 mg daily for low-grade adult acne vulgaris–a placebo-controlled, randomized double-blind study. J Eur Acad Dermatol Venereol. 2014 Jun;28(6):747–754.
   PubMed Web of Science ®Google Scholar
• Rao PK, Bhat RM, Nandakishore B, et al. Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris. Indian J Dermatol. 2014 May;59(3):316.
   PubMed Web of Science ®Google Scholar
• Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol. 2006 Apr;54(4):644–646.
   PubMed Web of Science ®Google Scholar
• Strauss JS, Leyden JJ, Lucky AW, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol. 2001 Aug;45(2):187–195.
   PubMed Web of Science ®Google Scholar
• Webster GF, Leyden JJ, Gross JA. Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne. J Drugs Dermatol. 2014 Jun;13(6):665–670.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ, Stein Gold L, Segal J, et al. An open-label, phase IV study evaluating lidose-isotretinoin administered without food in patients with severe recalcitrant nodular acne: low relapse rates observed over the 104-week post-treatment period. J Clin Aesthet Dermatol. 2019 Nov;12(11):13–18.
   PubMedGoogle Scholar
• Zaenglein AL, Segal J, Darby C, et al. Lidose-isotretinoin administered without food improves quality of life in patients with severe recalcitrant nodular acne: an open-label, single-arm, phase iv study. J Clin Aesthet Dermatol. 2020 Sep;13(9):15–20.
   PubMedGoogle Scholar
• Pandey D, Agrawal S. Efficacy of isotretinoin and antihistamine versus isotretinoin alone in the treatment of moderate to severe acne: a randomised control trial. Kathmandu Univ Med J (KUMJ). 2019 Jan–Mar;17(65):14–19.
   PubMedGoogle Scholar
• De D, Kanwar AJ. Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: a preliminary open-label, prospective, non-comparative, single-centre study. Clin Drug Investig. 2011;31(8):599–604.
   PubMed Web of Science ®Google Scholar
• Hasibur MR, Meraj Z. Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment. Mymensingh Med J. 2013 Jan;22(1):42–48.
   PubMedGoogle Scholar
• Wahab MA, Rahman MH, Monamie NS, et al. Isotretinoin versus weekly pulse dose azithromycin in the treatment of acne - a comparative study. J Pak Assoc Derma 2008;18(1):9–14. [ CENTRAL: CN-00789353].
   Google Scholar
• Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol. 2001 Nov-Dec;11(6):538–544.
   PubMed Web of Science ®Google Scholar
• Oprica C, Emtestam L, Hagströmer L, et al. Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris. Acta Derm Venereol. 2007;87(3):246–254.
   PubMed Web of Science ®Google Scholar
• Tan J, Humphrey S, Vender R, et al. POWER study group. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose Adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin. Br J Dermatol. 2014 Dec;171(6):1508–1516.
   PubMed Web of Science ®Google Scholar
• Dhir R, Gehi NP, Agarwal R, et al. Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne. Indian J Dermatol Venereol Leprol. 2008 Mar-Apr;74(2):187.
   PubMedGoogle Scholar
• Faghihi G, Rakhshanpour M, Abtahi-Naeini B, et al. The efficacy of 5% dapsone gel plus oral isotretinoin versus oral isotretinoin alone in acne vulgaris: a randomized double-blind study. Adv Biomed Res. 2014 Aug 22;3(1):177.
   PubMedGoogle Scholar
• Sardana K, Garg VK, Sehgal VN, et al. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol. 2009 May;23(5):556–560.
   PubMed Web of Science ®Google Scholar
• Xia J, Hu G, Hu D, et al. Concomitant use of 1,550-nm nonablative fractional laser with low-dose isotretinoin for the treatment of acne vulgaris in Asian patients: a randomized split-face controlled study. Dermatol Surg. 2018 Sep;44(9):1201–1208.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu J, Zhang Y, et al. Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: a randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects. Lasers Med Sci. 2021 Apr;36(3):657–665.
   PubMed Web of Science ®Google Scholar
• Ornelas J, Rosamilia L, Larsen L, et al. Objective assessment of isotretinoin-associated cheilitis: isotretinoin cheilitis grading scale. J Dermatolog Treat. 2016;27(2):153–155.
   PubMed Web of Science ®Google Scholar
• Ward A, Brogden RN, Heel RC, et al. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs. 1984 Jul;28(1):6–37.
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ. Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management. J Drugs Dermatol. 2013 Jun 1;12(6):626–631.
   PubMed Web of Science ®Google Scholar
• Elias PM. Epidermal effects of retinoids: supramolecular observations and clinical implications. J Am Acad Dermatol. 1986 Oct;15(4 Pt 2):797–809.
   PubMed Web of Science ®Google Scholar
• Bettoli V, Guerra-Tapia A, Herane MI, et al. Challenges and solutions in oral isotretinoin in acne: reflections on 35 years of experience. Clin Cosmet Investig Dermatol. 2019;12:943–951.
   PubMed Web of Science ®Google Scholar
• Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg. 2008 Sep;27(3):197–206.
   PubMed Web of Science ®Google Scholar
• Vallerand IA, Lewinson RT, Farris MS, et al. Efficacy and adverse events of oral isotretinoin for acne: a systematic review. Br J Dermatol. 2018 Jan;178(1):76–85.
   PubMed Web of Science ®Google Scholar
• Melnik BC. Overexpression of p53 explains isotretinoin’s teratogenicity. Exp Dermatol. 2018 Jan;27(1):91–93.
   PubMed Web of Science ®Google Scholar
• Bagatin E, Costa CS. The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol. 2020 Aug;13(8):885–897.
   PubMed Web of Science ®Google Scholar
• Hetzen PG, Carney JF, Walker AE, et al. Depression—a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol. 1983;9(2):278–279.
   Web of Science ®Google Scholar
• Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol. 2001 Oct;45(4):515–519.
   PubMed Web of Science ®Google Scholar
• Schwetz BA. New measures to manage risks associated with Accutane. JAMA. 2001;285(9):1146.
   PubMed Web of Science ®Google Scholar
• Magin P, Pond D, Smith W. Isotretinoin, depression and suicide: a review of the evidence. Br J Gen Pract. 2005 Feb;55(511):134–138.
   PubMed Web of Science ®Google Scholar
• Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2017 Jun;76(6):1068–1076.e9.
   PubMed Web of Science ®Google Scholar
• Li C, Chen J, Wang W, et al. Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis. BMJ Open. 2019 Jan 21;9(1):e021549.
   PubMed Web of Science ®Google Scholar
• Suarez B, Serrano A, Cova Y, et al. Isotretinoin was not associated with depression or anxiety: a twelve-week study. World J Psychiatry. 2016 Mar 22;6(1):136–142.
   PubMedGoogle Scholar
• Bremner JD, Shearer KD, McCaffery PJ. Retinoic acid and affective disorders: the evidence for an association. J Clin Psychiatry. 2012 Jan;73(1):37–50.
   PubMed Web of Science ®Google Scholar
• Goodfield MJ, Cox NH, Bowser A, et al. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. Br J Dermatol. 2010 Jun;162(6):1172–1179.
   PubMed Web of Science ®Google Scholar
• Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, et al. Isotretinoin and the eye: a review for the dermatologist. Dermatol Ther. 2020 Nov;33(6):e14029.
   PubMed Web of Science ®Google Scholar
• Demirok G, Topalak Y, Gündüz Ö, et al. The long-term effect of oral isotretinoin therapy on macula ganglion cell complex thickness. Cutan Ocul Toxicol. 2017 Sep;36(3):259–262.
   PubMed Web of Science ®Google Scholar
• Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001 Sep;132(3):299–305.
   PubMed Web of Science ®Google Scholar
• Citirik M, Tekin K. Excessive serous retinal detachment during the use of isotretinoin. Int Ophthalmol. 2018 Apr;38(2):763–766.
   PubMed Web of Science ®Google Scholar
• Onder HI, Turan H, Kilic AC, et al. Premacular hemorrhage due to isotretinoin use. Cutan Ocul Toxicol. 2013 Jun;32(2):170–172.
   PubMed Web of Science ®Google Scholar
• Labiris G, Katsanos A, Karapetsa M, et al. Association between isotretinoin use and central retinal vein occlusion in an adolescent with minor predisposition for thrombotic incidents: a case report. J Med Case Rep. 2009 Feb 10;3(1):58.
   PubMedGoogle Scholar
• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017 Jul;15(3):276–283.
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017 Jul;15(3):539–574.
   PubMed Web of Science ®Google Scholar
• Aslan Bayhan S, Bayhan HA, Çölgeçen E, et al. Effects of topical acne treatment on the ocular surface in patients with acne vulgaris. Cont Lens Anterior Eye. 2016 Dec;39(6):431–434.
   PubMed Web of Science ®Google Scholar
• Blackman HJ, Peck GL, Olsen TG, et al. Blepharoconjunctivitis: a side effect of 13-cis-retinoic acid therapy for dermatologic diseases. Ophthalmology. 1979;86(5):753–759.
   PubMed Web of Science ®Google Scholar
• Clayton JA, Longo DL. Dry eye. N Engl J Med. 2018 Jun 7;378(23):2212–2223.
   PubMed Web of Science ®Google Scholar
• Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007 Apr;5(2):163–178 .
   PubMed Web of Science ®Google Scholar
• Carracedo G, Pastrana C, Serramito M, et al. Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation. Acta Ophthalmol. 2019 Mar;97(2):e162–e169.
   PubMed Web of Science ®Google Scholar
• Karaosmanoğlu N, Mülkoğlu C. Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study.BMC Musculoskelet Disord. 2020;21(1):631. Published 2020 Sep 25.
   PubMed Web of Science ®Google Scholar
• Nesher G, Zuckner J. Rheumatologic complications of vitamin A and retinoids. Semin Arthritis Rheum. 1995 Feb;24(4):291–296.
   PubMed Web of Science ®Google Scholar
• Lowenstein EB, Lowenstein EJ. Isotretinoin systemic therapy and the shadow cast upon dermatology’s downtrodden hero. Clin Dermatol. 2011 Nov-Dec;29(6):652–661.
   PubMed Web of Science ®Google Scholar
• Pedraz T, Martínez A, Pascual E. Acute hip monoarthritis in a patient treated with isotretinoin. J Clin Rheumatol. 2006 Apr;12(2):105–106.
   PubMed Web of Science ®Google Scholar
• Hughes RA. Arthritis precipitated by isotretinoin treatment for acne vulgaris. J Rheumatol. 1993 Jul;20(7):1241–1242.
   PubMed Web of Science ®Google Scholar
• DiGiovanna JJ, Helfgott RK, Gerber LH, et al. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. N Engl J Med. 1986 Nov 6;315(19):1177–1182.
   PubMed Web of Science ®Google Scholar
• Pehlivan Y, Kisacik B, Sayiner ZA, et al. Inflammatory back pain in patients treated with isotretinoin. J Rheumatol. 2011 Dec;38(12):2690.
   PubMed Web of Science ®Google Scholar
• Lebwohl B, Sundström A, Jabri B, et al. Isotretinoin use and celiac disease: a population-based cross-sectional study. Am J Clin Dermatol. 2014;15(6):537–542.
   PubMed Web of Science ®Google Scholar
• Rashtak S, Khaleghi S, Marietta EV, et al. Isotretinoin exposure and risk of celiac disease. PLoS One. 2015;10(8):e0135881. Published 2015 Aug 19.
   PubMed Web of Science ®Google Scholar
• Wright S, Strunk A, Garg A. Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin. J Am Acad Dermatol. 2021 Jan;84(1):41–45.
   PubMed Web of Science ®Google Scholar
• Rashtak S, Khaleghi S, Pittelkow MR, et al. Isotretinoin exposure and risk of inflammatory bowel disease. JAMA Dermatol. 2014 Dec;150(12):1322–1326.
   PubMed Web of Science ®Google Scholar
• Le CL, Lebrun -Vignes B, Bachelot A, et al. Guidelines for the management of acne: recommendations from a French multidisciplinary group. Br J Dermatol. 2017;177(4):908–913.
   PubMed Web of Science ®Google Scholar
• Asai Y, Baibergenova A, Dutil M, et al. Management of acne: Canadian clinical practice guideline. CMAJ. 2016;188(2):118–126.
   PubMed Web of Science ®Google Scholar
• Nast A, Dreno B, Bettoli V, et al. European evidence -based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(1):1–29.
   PubMedGoogle Scholar
• Lee YH, Scharnitz TP, Muscat J, et al. Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta - analysis. JAMA Dermatol. 2016;152(1):35–44.
   PubMed Web of Science ®Google Scholar
• Barbieri JS, Shin DB, Wang S, et al. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol. 2020;82(1):72–79.
   PubMed Web of Science ®Google Scholar
• Hansen TJ, Lucking S, Miller JJ, et al. Standardized laboratory monitoring with use of isotretinoin in acne. J Am Acad Dermatol. 2016;75(2):323–328.
   PubMed Web of Science ®Google Scholar
• Opel D, Kramer ON, Chevalier M, et al. Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin associated pancreatitis. Br J Dermatol. 2017;177(4):960–966.
   PubMed Web of Science ®Google Scholar
• Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg. 2001;20(3):166–183.
   PubMed Web of Science ®Google Scholar
• Krishna S, Okhovat J-P, Kim J, et al. Influence of ω-3 fatty acids on triglyceride levels in patients using isotretinoin. JAMA Dermatol. 2015;151(1):101.
   PubMed Web of Science ®Google Scholar
• Krishna S, KIM C. The effect of omega-3 fatty acid on triglyceride levels in patients using isotretinoin. J Am Acad Dermatol. 2012;66(4):AB19.
   Web of Science ®Google Scholar
• Lyons F, Laker MF, Marsden JR, et al. Effect of oral 13-cis-retinoic acid on serum lipids. Br J Dermatol. 1982;107(5):591–595.
   PubMed Web of Science ®Google Scholar
• Marsden JR. Effect of dietary fish oil on hyperlipidaemia due to isotretinoin and etretinate. Hum Exp Toxicol. 1987;6(3):219–222.
   Google Scholar
• Rodondi N, Darioli R, Ramelet AA, et al. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med. 2002;136(8):582–589.
   PubMed Web of Science ®Google Scholar
• Marson JW, Baldwin HE. New concepts, concerns, and creations in acne. Dermatol Clin. 2019;37(1):1–9.
   PubMed Web of Science ®Google Scholar
• Landis MN. Optimizing isotretinoin treatment of acne: update on current recommendations for monitoring, dosing, safety, adverse effects, compliance, and outcomes. Am J Clin Dermatol. 2020 Jun;21(3):411–419.
   PubMed Web of Science ®Google Scholar
• Preneau S, Dessinioti C, Nguyen JM, et al. Predictive markers of response to isotretinoin in female acne. Eur J Dermatol. 2013 Jul-Aug;23(4):478–486.
   PubMed Web of Science ®Google Scholar
• Villani A, Carmela Annunziata M, Antonietta Luciano M, et al. Skin needling for the treatment of acne scarring: a comprehensive review. J Cosmet Dermatol. 2020 Sep;19(9):2174–2181.
   PubMed Web of Science ®Google Scholar